Category : Search result: biotech setback

CRISPR Therapy Hits Major Roadblock: Intellia Pauses Phase 3 Trial After Patient Suffers Severe Liver Reaction

CRISPR Therapy Paused After Patient Liver Reaction

In a significant setback for gene editing medicine, Intellia Therapeutics halts its Phase 3 ATTR trial following a serious liver adverse event in a patient receiving CRISPR-based treatment NZ-1.

Novartis Nears Blockbuster $1.7 Billion Acquisition of Biotech Pioneer Avidity Biosciences

Novartis Nears $1.7B Avidity Biosciences Acquisition

Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.

Mehul Choksi Extradition Hit: Belgian Court Deems Defence Arguments 'Irrelevant' in Major Setback

Belgian court rejects Choksi's defence in extradition case

In a significant legal blow to fugitive diamantaire Mehul Choksi, a Belgian court has rejected his defence arguments as irrelevant to his extradition case, dealing a major setback to his attempts to avoid facing Indian authorities.

Page 1 of 1